EUVIMEDSkopri EUVIMED
KorrekturStudienprotokollOpen access · CC BY 4.0

Correction: Efficacy and safety of the ayurvedic formulation ‘Trikatu’ as an add-on to standard care in dyslipidemia: Study protocol for a randomized, double-blind, placebo-controlled trial evaluating lipid parameters, and gut microbiota

Shruti Khanduri, Sophia Jameela, Suchanda Sahu, Sujata Devi, Bhogavalli Chandra Sekhara Rao, Kshirod Ratha, Richa Singhal, Latika Kaushik, Narayanam Srikanth, Rabinarayan Acharya

PLOS One · 2026-06-12 · 21 (6) · e0351663

DOI: 10.1371/journal.pone.0351663 ↗

At a glance

Korrektur in PLOS One, published online on 2026-06-12. Written by Shruti Khanduri and 9 co-authors. 1 references. The full text is freely available (open access, CC BY 4.0).

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Ebda abstract disponibbli.

Cite

APA

Khanduri, S., Jameela, S., Sahu, S., Devi, S., Rao, B. C. S., Ratha, K., Singhal, R., Kaushik, L., Srikanth, N., & Acharya, R. (2026). Correction: Efficacy and safety of the ayurvedic formulation ‘Trikatu’ as an add-on to standard care in dyslipidemia: Study protocol for a randomized, double-blind, placebo-controlled trial evaluating lipid parameters, and gut microbiota. PLOS One, 21(6), e0351663. https://doi.org/10.1371/journal.pone.0351663

Vancouver

Khanduri S, Jameela S, Sahu S, Devi S, Rao BCS, Ratha K, et al. Correction: Efficacy and safety of the ayurvedic formulation ‘Trikatu’ as an add-on to standard care in dyslipidemia: Study protocol for a randomized, double-blind, placebo-controlled trial evaluating lipid parameters, and gut microbiota. PLOS One. 2026;21(6):e0351663. doi:10.1371/journal.pone.0351663

BibTeX
@article{Khanduri2026,
  author = {Khanduri, Shruti and Jameela, Sophia and Sahu, Suchanda and Devi, Sujata and Rao, Bhogavalli Chandra Sekhara and Ratha, Kshirod and Singhal, Richa and Kaushik, Latika and Srikanth, Narayanam and Acharya, Rabinarayan},
  title = {Correction: Efficacy and safety of the ayurvedic formulation ‘Trikatu’ as an add-on to standard care in dyslipidemia: Study protocol for a randomized, double-blind, placebo-controlled trial evaluating lipid parameters, and gut microbiota},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0351663},
  doi = {10.1371/journal.pone.0351663}
}
Start for free →